NEXVIAZYME (alglucosidase α) is a drug for the treatment of Pompe disease. Its detailed Chinese instructions, purchase channels and precautions are important for patients. This article aims to provide patients with comprehensive information about NEXVIAZYME. The following is a detailed introduction.
Instructions for NEXVIAZYME
The instructions for NEXVIAZYME detail the basic information, indications, dosage, adverse reactions and precautions of the drug, and are an important reference for patients to use the drug correctly.
Basic information
NEXVIAZYME (alglucosidase α) is a drug developed by the French Sanofi Group for the treatment of patients with late-onset Pompe disease (lysosomal acid α-glucosidase deficiency) aged 1 year and above. It exists in the form of an injection, and its main ingredient is recombinant human acid α-glucosidase.
Indications and Dosages
NEXVIAZYME is indicated for the treatment of patients with late-onset Pompe disease and is administered by intravenous infusion. The dosage is adjusted according to the patient's weight, and the recommended dosage is 20 mg/kg (weight ≥ 30 kg) or 40 mg/kg (weight < 30 kg) every two weeks. Reconstitution and dilution are required before infusion, and the patient's reaction should be closely monitored during the infusion.
Adverse reactions and precautions
Adverse reactions that may be caused by the use of NEXVIAZYME include headache, fatigue, diarrhea, etc. Before administration, it is recommended to use antihistamines and other drugs for pretreatment to reduce the risk of allergic reactions. For patients with severe adverse reactions, the drug should be discontinued immediately and appropriate treatment measures should be taken.
The NEXVIAZYME instructions provide patients with comprehensive information about the drug, which helps patients to correctly understand and use the drug. While following the instructions, patients should also pay close attention to their own reactions to prevent medication risks.
Purchase channels and precautions for NEXVIAZYME
Choosing a suitable purchase channel and understanding relevant precautions are important for patients to obtain formal and safe NEXVIAZYME.
Formal purchasing channels
NEXVIAZYME is a prescription drug and should be purchased through formal channels, such as hospital pharmacies, large chain drugstores or authorized online pharmacies. When purchasing, patients should request information such as the formal invoice and drug traceability code of the drug to verify the quality of the drug.
Price and medical insurance policy
NEXVIAZYME is expensive, and patients need to pay attention to medical insurance policies to reduce the financial burden. At present, the drug has not been widely included in the medical insurance system, but some regions may have specific reimbursement policies or patient assistance programs. Patients should keep abreast of relevant policy information and consult medical insurance departments or medical institutions for help.
Purchase precautions
When purchasing NEXVIAZYME, patients should pay attention to information such as the packaging, expiration date and storage conditions of the drug. Ensure that the drug packaging is intact and undamaged, and use it within the expiration date. At the same time, store the drug according to the instructions, avoid direct sunlight and high temperature environment, and ensure that the quality of the drug is not affected.
Choosing the right purchase channel and understanding the relevant precautions are the key for patients to obtain formal and safe NEXVIAZYME. Patients should pay attention to medical insurance policies to reduce the financial burden, and carefully check the drug information when purchasing to prevent medication risks.
